The new drug compound Salirasib has shown positive results against pancreatic cancer and recently passed Phase I/II clinical trials. The drug, given in combination with gemcitabine, the standard drug used to combat pancreatic cancer, almost doubled the life expectancy of those who received it.
Full article >>
Tuesday, July 21, 2009
New Drug Candidate Prolongs The Lives Of Pancreatic Cancer Patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment